Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 34 matching records.
34 results — page 1 of 2
- Level BClinical TrialPubMed
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study.
Clinical Trial on Chronic Kidney Disease, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Transl Med - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells combined with platelet-rich plasma for periodontal regeneration: a multicenter, randomized, open-label, parallel-group comparative trial.
Clinical Trial with a reported sample of 21, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 21
Regen Ther1 citations - Level BClinical TrialPubMed
Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study.
Clinical Trial with a reported sample of 24 on Tendon Injury, Rotator Cuff, published in J Shoulder Elbow Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
J Shoulder Elbow Surg - Level ASystematic ReviewPubMed
Comparative Efficacy and Safety of Intra-Articular Adipose-Derived, Bone Marrow-Derived, and Peripheral Blood-Derived Stem Cell Injections for Knee Osteoarthritis: A Systematic Review.
Systematic Review with a reported sample of 1247 on Knee Osteoarthritis, Osteoarthritis, published in Bioengineering (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 1247
Bioengineering (Basel) - Level BClinical TrialPubMed
Study protocol for a randomized clinical trial evaluating the safety and efficacy of autologous adipose-derived stem cell therapy for ulcers in patients with critical limb ischemia.
Clinical Trial on Peripheral Artery Disease, published in PLoS One (2025) — summary generated from the PubMed abstract.
- 2025
PLoS One - Level BClinical TrialPubMed
Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.
Clinical Trial on Chronic Wound, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level BRandomized Controlled TrialPubMed
Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial.
Randomized Controlled Trial with a reported sample of 40 on Neuroinflammation, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
- n = 40
Front Neurol - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.
Clinical Trial with a reported sample of 114 on Scar, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 114
Stem Cell Res Ther - Level CProspective StudyPubMed
Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoar
Prospective Study on Knee Osteoarthritis, Osteoarthritis, published in Stem Cells Dev (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cells Dev5 citations - Level BRandomized Controlled TrialPubMed
Safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell preparation in the treatment of knee osteoarthritis: A Phase I/IIa randomised controlled trial.
Randomized Controlled Trial with a reported sample of 40 on Knee Osteoarthritis, Osteoarthritis, published in Osteoarthr Cartil Open (2024) — summary generated from the PubMed abstract.
- 2024
- n = 40
Osteoarthr Cartil Open10 citations - Level ASystematic ReviewPubMed
Safety and Efficacy of Adipose-Derived Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: A Systematic Review.
Systematic Review on Cardiovascular Disease, published in Arq Bras Cardiol (2024) — summary generated from the PubMed abstract.
- 2024
Arq Bras Cardiol3 citations - Level CProspective StudyPubMed
Safety and efficacy of adipose-derived mesenchymal stem cell therapy in elderly Parkinson's disease patients: an intermediate-size expanded access program.
Prospective Study on Neuroinflammation, published in Cytotherapy (2024) — summary generated from the PubMed abstract.
- 2024
Cytotherapy1 citations - Level DAnimal StudyPubMed
Adipose-derived mesenchymal stromal cells: A study on safety and efficacy in ocular inflammation.
Animal Study on Immune Modulation, published in Ocul Surf (2024) — summary generated from the PubMed abstract.
- 2024
Ocul Surf3 citations - Level ASystematic ReviewPubMed
Safety and efficacy of autologous adipose-derived stem cells for knee osteoarthritis in the elderly population: A systematic review.
Systematic Review with a reported sample of 339 on Knee Osteoarthritis, Osteoarthritis, published in J Clin Orthop Trauma (2024) — summary generated from the PubMed abstract.
- 2024
- n = 339
J Clin Orthop Trauma7 citations - Level ARandomized Controlled TrialPubMed
Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial.
Randomized Controlled Trial with a reported sample of 261 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Am J Sports Med (2023) — summary generated from the PubMed abstract.
- 2023
- n = 261
Am J Sports Med91 citations - Level BClinical TrialPubMed
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol
Clinical Trial with a reported sample of 18 on Systemic / IV, published in Neurosurg Pract (2023) — summary generated from the PubMed abstract.
- 2023
- n = 18
Neurosurg Pract6 citations - Level BClinical TrialPubMed
Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial.
Clinical Trial on Autoimmune Research, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther39 citations - Level AMeta-analysisPubMed
Safety and efficacy of adipose-derived mesenchymal stem cells for knee osteoarthritis: A systematic review and m-analysis.
Meta-analysis with a reported sample of 463 on Knee Osteoarthritis, Osteoarthritis, published in Joint Bone Spine (2022) — summary generated from the PubMed abstract.
- 2022
- n = 463
Joint Bone Spine27 citations - Level BClinical TrialPubMed
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, pha
Clinical Trial with a reported sample of 3 on Hair & Scalp, published in J Ovarian Res (2021) — summary generated from the PubMed abstract.
- 2021
- n = 3
J Ovarian Res59 citations - Level BClinical TrialPubMed
Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: Safety and evidence of efficacy at 1 year.
Clinical Trial with a reported sample of 51 on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Stem Cells Transl Med (2021) — summary generated from the PubMed abstract.
- 2021
- n = 51
Stem Cells Transl Med54 citations - Level ASystematic ReviewPubMed
The safety and efficacy of autologous adipose-derived stromal vascular fraction for nonscarring alopecia: A systematic review.
Systematic Review with a reported sample of 188 on Scar, Hair Loss, Hair Regeneration, published in Arch Dermatol Res (2021) — summary generated from the PubMed abstract.
- 2021
- n = 188
Arch Dermatol Res6 citations - Level CCase Report / SeriesPubMed
Efficacy and safety of autologous adipose-derived stromal vascular fraction enriched with platelet-rich plasma in flap repair of transsphincteric cryptoglandular fistulas.
Case Report / Series with a reported sample of 38 on Chronic Wound, Scar, Immune Modulation, Autoimmune Research, published in Tech Coloproctol (2021) — summary generated from the PubMed abstract.
- 2021
- n = 38
Tech Coloproctol15 citations - Level CProspective StudyPubMed
Safety and Efficacy of Human Adipose-Derived Stromal/Stem Cell Therapy in an Immunocompetent Murine Pressure Ulcer Model.
Prospective Study on Chronic Wound, published in Stem Cells Dev (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Dev15 citations - Level CProspective StudyPubMed
Intrathecal Infusion of Autologous Adipose-Derived Regenerative Cells in Autoimmune Refractory Epilepsy: Evaluation of Safety and Efficacy.
Prospective Study on Autoimmune Research, published in Stem Cells Int (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Int18 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406